Loading insider details...
Latest Form 4 (Jul 2, 2026): Sale of 3,389 KYMR shares, $387.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Kymera Therapeutics, Inc. (KYMR) | Sale | 3,389 | $387.3K |
| Jun 25, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 5,000 | $105.3K |
| Jun 22, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 2,500 | $52.6K |
| Apr 16, 2026 | Kymera Therapeutics, Inc. (KYMR) | Sale | 1,347 | $121.2K |
| Apr 10, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 2,500 | $52.6K |
| Mar 4, 2026 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 9,225 | n/a |
| Apr 9, 2025 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 50,000 | n/a |